Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Giorgio Treglia, Paola Castaldi, Maria Felicia Villani, Germano Perotti, Chiara De Waure, Angelina Filice, Valentina Ambrosini, Nadia Cremonini, Monica Santimaria, Annibale Versari, Stefano Fanti, Alessandro Giordano, Vittoria Rufini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

90 Citazioni (Scopus)

Abstract

To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels.
Lingua originaleEnglish
pagine (da-a)569-580
Numero di pagine12
RivistaEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume39
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Calcitonin
  • Dihydroxyphenylalanine
  • Female
  • Fluorodeoxyglucose F18
  • Gallium Radioisotopes
  • Humans
  • Individualized Medicine
  • Male
  • Middle Aged
  • Positron-Emission Tomography and Computed Tomography
  • Recurrence
  • Retrospective Studies
  • Somatostatin
  • Thyroid Neoplasms

Fingerprint

Entra nei temi di ricerca di 'Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma'. Insieme formano una fingerprint unica.

Cita questo